Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up

This publication has 31 references indexed in Scilit:

• Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study
  Journal of Cardiovascular Magnetic Resonance, 2012
• Mortality in myotonic dystrophy patients in the area of prophylactic pacing devices
  International Journal of Cardiology, 2011
• Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
  Neurology, 2011
• Cardiac Involvement in Patients With Muscular Dystrophies
  Circulation: Cardiovascular Imaging, 2011
• Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1
  Neurology, 2010
• Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing
  JACC, 2002
• Paramyotonia congenita: Abnormal short exercise test, and improvement after mexiletine therapy
  Muscle & Nerve, 1994
• Treatment of myotonia with antiarrhythmic drugs
  Acta Neurologica Scandinavica, 1992
• Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine
  Acta Paediatrica, 1992
• Effects of Antiarrhythmic Drugs on AV Nodal and Intraventricular Conduction as Assessed in the Isolated, Blood-Perfused AV Node Preparation of the Dog
  Journal of Cardiovascular Pharmacology, 1981